The Role of the Phospho-CDK2/Cyclin A Recruitment Site in Substrate Recognition*

Phospho-CDK2/cyclin A, a kinase that is active in cell cycle S phase, contains an RXL substrate recognition site that is over 40 Å from the catalytic site. The role of this recruitment site, which enhances substrate affinity and catalytic efficiency, has been investigated using peptides derived from the natural substrates, namely CDC6 and p107, and a bispeptide inhibitor in which the γ-phosphate of ATP is covalently attached by a linker to the CDC6 substrate peptide. X-ray studies with a 30-residue CDC6 peptide in complex with pCDK2/cyclin A showed binding of a dodecamer peptide at the recruitment site and a heptapeptide at the catalytic site, but no density for the linking 11 residues. Kinetic studies established that the CDC6 peptide had an 18-fold lower Km compared with heptapeptide substrate and that this effect required the recruitment peptide to be covalently linked to the substrate peptide. X-ray studies with the CDC6 bispeptide showed binding of the dodecamer at the recruitment site and the modified ATP in two alternative conformations at the catalytic site. The CDC6 bispeptide was a potent inhibitor competitive with both ATP and peptide substrate of pCDK2/cyclin A activity against a heptapeptide substrate (Ki = 0.83 nm) but less effective against RXL-containing substrates. We discuss how localization at the recruitment site (KD 0.4 μm) leads to increased catalytic efficiency and the design of a potent inhibitor. The notion of a flexible linker between the sites, which must have more than a minimal number of residues, provides an explanation for recognition and discrimination against different substrates.

[1]  P. Guida,et al.  DP1 phosphorylation in multimeric complexes: weaker interaction with cyclin A through the E2F1 cyclin A binding domain leads to more efficient phosphorylation than stronger interaction through the p107 cyclin A binding domain. , 1999, Biochemical and biophysical research communications.

[2]  J. Herrero,et al.  Exceptional Disfavor for Proline at the P+1 Position among AGC and CAMK Kinases Establishes Reciprocal Specificity between Them and the Proline-directed Kinases* , 2005, Journal of Biological Chemistry.

[3]  Zhou Songyang,et al.  Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.

[4]  L. Johnson,et al.  The crystal structure of human CDK7 and its protein recognition properties. , 2004, Structure.

[5]  M. Ewen,et al.  Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. , 1992, Science.

[6]  Anindya Dutta,et al.  Cyclin-binding motifs are essential for the function of p21CIP1 , 1996, Molecular and cellular biology.

[7]  J. Harper,et al.  Cyclin-dependent kinases. , 2001, Chemical reviews.

[8]  S. Taylor,et al.  Phosphorylation modulates catalytic function and regulation in the cAMP-dependent protein kinase. , 1995, Biochemistry.

[9]  K. Vrana,et al.  Adenosine cyclic 3',5'-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit. , 1982, Biochemistry.

[10]  K. Weinberg,et al.  Discovery of a Regulatory Motif That Controls the Exposure of Specific Upstream Cyclin-dependent Kinase Sites That Determine Both Conformation and Growth Suppressing Activity of pRb* , 1999, The Journal of Biological Chemistry.

[11]  W. Kaelin,et al.  Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Johnson,et al.  Effects of Phosphorylation of Threonine 160 on Cyclin-dependent Kinase 2 Structure and Activity* , 1999, The Journal of Biological Chemistry.

[13]  W. Bode,et al.  A player of many parts: the spotlight falls on thrombin's structure. , 1993, Thrombosis research.

[14]  Philip D. Jeffrey,et al.  Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.

[15]  J. Peters,et al.  A Conserved Cyclin-Binding Domain Determines Functional Interplay between Anaphase-Promoting Complex–Cdh1 and Cyclin A-Cdk2 during Cell Cycle Progression , 2001, Molecular and Cellular Biology.

[16]  Ricardo M Biondi,et al.  Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. , 2003, The Biochemical journal.

[17]  L. Johnson,et al.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.

[18]  W. Sellers,et al.  Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors , 1996, Molecular and cellular biology.

[19]  B. Dynlacht,et al.  p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. , 1995, Genes & development.

[20]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[21]  L. Johnson,et al.  Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. , 2001, Molecular cell.

[22]  J. Adams,et al.  Chemical Clamping Allows for Efficient Phosphorylation of the RNA Carrier Protein Npl3* , 2004, Journal of Biological Chemistry.

[23]  E. Goldsmith,et al.  Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. , 2004, Molecular cell.

[24]  M. Noble,et al.  Reversal of Growth Suppression by p107 via Direct Phosphorylation by Cyclin D1/Cyclin-Dependent Kinase 4 , 2002, Molecular and Cellular Biology.

[25]  E. Krebs,et al.  Substrate specificity of the cyclic AMP-dependent protein kinase. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Hannon,et al.  Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. , 1993, Genes & development.

[27]  S. Hubbard,et al.  Probing the Catalytic Mechanism of the Insulin Receptor Kinase with a Tetrafluorotyrosine-containing Peptide Substrate* , 2000, The Journal of Biological Chemistry.

[28]  B. Schulman,et al.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Robert Huber,et al.  Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex , 2000, Nature.

[30]  S. West,et al.  CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair , 2005, Nature.

[31]  D. Takeda,et al.  Mutational Analysis of the Cy Motif from p21 Reveals Sequence Degeneracy and Specificity for Different Cyclin-Dependent Kinases , 2001, Molecular and Cellular Biology.

[32]  B. Dynlacht,et al.  Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. , 1998, Genes & development.

[33]  L. Johnson,et al.  The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2‐independent roles , 2005, The EMBO journal.

[34]  P. Cole,et al.  Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A. , 2004, Bioorganic & medicinal chemistry letters.

[35]  J. Diffley,et al.  CDKs Promote DNA Replication Origin Licensing in Human Cells by Protecting Cdc6 from APC/C-Dependent Proteolysis , 2005, Cell.

[36]  H. Koeppen,et al.  Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth. , 2003, Cancer research.

[37]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[38]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[39]  L. Pearl,et al.  Regulation of Hsp90 ATPase Activity by the Co-chaperone Cdc37p/p50 cdc37 * , 2002, The Journal of Biological Chemistry.

[40]  S. Reed,et al.  Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. , 1992, Genes & development.

[41]  M. Ewen,et al.  Interaction between human cyclin A and adenovirus E1A-associated p107 protein. , 1992, Science.

[42]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[43]  Nguyen-Huu Xuong,et al.  Crystal Structure of a Complex Between the Catalytic and Regulatory (RIα) Subunits of PKA , 2005, Science.

[44]  T. Hupp,et al.  The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A. , 2000, Journal of molecular biology.

[45]  G. Siligardi,et al.  Biomolecules interactions and competitions by non-immobilised ligand interaction assay by circular dichroism. , 1998, Enantiomer.

[46]  G. Gilliland,et al.  Crystal structure of the complex between thrombin and the central "E" region of fibrin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Anindya Dutta,et al.  A Bipartite Substrate Recognition Motif for Cyclin-dependent Kinases* , 2001, The Journal of Biological Chemistry.

[48]  James U Bowie,et al.  Mae inhibits Pointed‐P2 transcriptional activity by blocking its MAPK docking site , 2006, The EMBO journal.

[49]  Ivo Tews,et al.  Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. , 2002, Biochemistry.

[50]  S. Hubbard,et al.  Mechanism-based design of a protein kinase inhibitor , 2001, Nature Structural Biology.

[51]  P. Fowler,et al.  Substrate Specificity of CDK2-Cyclin A , 2003, Journal of Biological Chemistry.

[52]  S. Hubbard.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog , 1997, The EMBO journal.

[53]  J. Adams,et al.  Phosphoryl Transfer Step in the C-terminal Src Kinase Controls Src Recognition* , 2005, Journal of Biological Chemistry.

[54]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[55]  P. Fischer,et al.  Design, synthesis, biological activity and structural analysis of cyclic peptide inhibitors targeting the substrate recruitment site of cyclin-dependent kinase complexes. , 2004, Organic & biomolecular chemistry.

[56]  Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism. , 2002, Biochemistry.

[57]  W. Sellers,et al.  Retinoblastoma Protein Contains a C-terminal Motif That Targets It for Phosphorylation by Cyclin-cdk Complexes , 1999, Molecular and Cellular Biology.